

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 6.04708823 |
| 2 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.53758036 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.50652630 |
| 4 | vocalization behavior (GO:0071625) | 5.38113297 |
| 5 | synaptic vesicle maturation (GO:0016188) | 5.27772521 |
| 6 | locomotory exploration behavior (GO:0035641) | 5.17350394 |
| 7 | * synaptic vesicle exocytosis (GO:0016079) | 5.02385839 |
| 8 | glutamate secretion (GO:0014047) | 4.88865460 |
| 9 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.83216154 |
| 10 | protein localization to synapse (GO:0035418) | 4.74798404 |
| 11 | neuron cell-cell adhesion (GO:0007158) | 4.71533660 |
| 12 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.71181338 |
| 13 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 4.64822807 |
| 14 | neuronal action potential propagation (GO:0019227) | 4.54305529 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.49571199 |
| 16 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.48070480 |
| 17 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 4.39592468 |
| 18 | neurotransmitter secretion (GO:0007269) | 4.36243073 |
| 19 | regulation of synaptic vesicle transport (GO:1902803) | 4.30228277 |
| 20 | glutamate receptor signaling pathway (GO:0007215) | 4.28358138 |
| 21 | synaptic transmission, glutamatergic (GO:0035249) | 4.27015064 |
| 22 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.23054613 |
| 23 | exploration behavior (GO:0035640) | 4.16489071 |
| 24 | neuron-neuron synaptic transmission (GO:0007270) | 4.09484812 |
| 25 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.07960911 |
| 26 | cerebellar Purkinje cell differentiation (GO:0021702) | 4.05066362 |
| 27 | regulation of neuronal synaptic plasticity (GO:0048168) | 4.01583643 |
| 28 | cellular potassium ion homeostasis (GO:0030007) | 3.99825907 |
| 29 | positive regulation of membrane potential (GO:0045838) | 3.85971256 |
| 30 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.85118702 |
| 31 | gamma-aminobutyric acid transport (GO:0015812) | 3.83521736 |
| 32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.82683449 |
| 33 | long-term memory (GO:0007616) | 3.80966454 |
| 34 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.80636865 |
| 35 | regulation of postsynaptic membrane potential (GO:0060078) | 3.76781420 |
| 36 | layer formation in cerebral cortex (GO:0021819) | 3.68064931 |
| 37 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.67227778 |
| 38 | dendritic spine morphogenesis (GO:0060997) | 3.67158169 |
| 39 | positive regulation of synapse maturation (GO:0090129) | 3.66941591 |
| 40 | neurotransmitter transport (GO:0006836) | 3.65547877 |
| 41 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.58610168 |
| 42 | proline transport (GO:0015824) | 3.56119634 |
| 43 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.53885276 |
| 44 | synaptic vesicle endocytosis (GO:0048488) | 3.53711195 |
| 45 | presynaptic membrane assembly (GO:0097105) | 3.52964554 |
| 46 | regulation of synapse structural plasticity (GO:0051823) | 3.52286692 |
| 47 | neuromuscular process controlling posture (GO:0050884) | 3.51233119 |
| 48 | neuron recognition (GO:0008038) | 3.45962433 |
| 49 | startle response (GO:0001964) | 3.45003580 |
| 50 | response to histamine (GO:0034776) | 3.43493722 |
| 51 | membrane hyperpolarization (GO:0060081) | 3.42400986 |
| 52 | long-term synaptic potentiation (GO:0060291) | 3.40527299 |
| 53 | transmission of nerve impulse (GO:0019226) | 3.39553414 |
| 54 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.38714202 |
| 55 | postsynaptic membrane organization (GO:0001941) | 3.38661153 |
| 56 | neuronal ion channel clustering (GO:0045161) | 3.37850602 |
| 57 | innervation (GO:0060384) | 3.37370496 |
| 58 | regulation of neurotransmitter secretion (GO:0046928) | 3.35583840 |
| 59 | membrane depolarization during action potential (GO:0086010) | 3.34904934 |
| 60 | cerebellar granule cell differentiation (GO:0021707) | 3.34542723 |
| 61 | regulation of synaptic plasticity (GO:0048167) | 3.34060513 |
| 62 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 3.33998430 |
| 63 | regulation of vesicle fusion (GO:0031338) | 3.33652462 |
| 64 | sodium ion export (GO:0071436) | 3.32931558 |
| 65 | regulation of neurotransmitter levels (GO:0001505) | 3.30426195 |
| 66 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.27437373 |
| 67 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 3.26394573 |
| 68 | membrane depolarization (GO:0051899) | 3.22922299 |
| 69 | presynaptic membrane organization (GO:0097090) | 3.22601586 |
| 70 | detection of calcium ion (GO:0005513) | 3.22453119 |
| 71 | activation of protein kinase A activity (GO:0034199) | 3.19719533 |
| 72 | chemosensory behavior (GO:0007635) | 3.19669413 |
| 73 | pyrimidine nucleobase catabolic process (GO:0006208) | 3.18950623 |
| 74 | synapse assembly (GO:0007416) | 3.18110552 |
| 75 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 3.17468853 |
| 76 | axonal fasciculation (GO:0007413) | 3.17288742 |
| 77 | positive regulation of dendritic spine development (GO:0060999) | 3.09941715 |
| 78 | central nervous system projection neuron axonogenesis (GO:0021952) | 3.08557522 |
| 79 | regulation of neurotransmitter transport (GO:0051588) | 3.08002841 |
| 80 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.07535605 |
| 81 | cell communication by electrical coupling (GO:0010644) | 3.07496016 |
| 82 | mechanosensory behavior (GO:0007638) | 3.06502115 |
| 83 | dendrite morphogenesis (GO:0048813) | 3.06189822 |
| 84 | adult walking behavior (GO:0007628) | 3.04833135 |
| 85 | behavioral fear response (GO:0001662) | 3.04015965 |
| 86 | behavioral defense response (GO:0002209) | 3.04015965 |
| 87 | learning (GO:0007612) | 3.01395380 |
| 88 | fear response (GO:0042596) | 3.00736083 |
| 89 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.00409828 |
| 90 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.99711682 |
| 91 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.99145387 |
| 92 | cell migration in hindbrain (GO:0021535) | 2.98879687 |
| 93 | negative regulation of dendrite development (GO:2000171) | 2.97492088 |
| 94 | neuromuscular synaptic transmission (GO:0007274) | 2.97468342 |
| 95 | intraspecies interaction between organisms (GO:0051703) | 2.97221031 |
| 96 | social behavior (GO:0035176) | 2.97221031 |
| 97 | establishment of mitochondrion localization (GO:0051654) | 2.97205563 |
| 98 | nucleobase catabolic process (GO:0046113) | 2.97086151 |
| 99 | synaptic transmission (GO:0007268) | 2.96743628 |
| 100 | positive regulation of neurotransmitter transport (GO:0051590) | 2.96051879 |
| 101 | response to pheromone (GO:0019236) | 2.95970993 |
| 102 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.95856976 |
| 103 | neuromuscular process controlling balance (GO:0050885) | 2.95825459 |
| 104 | cell differentiation in hindbrain (GO:0021533) | 2.95559031 |
| 105 | auditory behavior (GO:0031223) | 2.93617739 |
| 106 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.93202458 |
| 107 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.92247912 |
| 108 | regulation of synapse maturation (GO:0090128) | 2.89787597 |
| 109 | long term synaptic depression (GO:0060292) | 2.89120492 |
| 110 | response to auditory stimulus (GO:0010996) | 2.89026282 |
| 111 | cochlea development (GO:0090102) | 2.88611857 |
| 112 | synapse organization (GO:0050808) | 2.88256125 |
| 113 | serotonin metabolic process (GO:0042428) | 2.88045018 |
| 114 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.88027003 |
| 115 | potassium ion homeostasis (GO:0055075) | 2.87183706 |
| 116 | regulation of dendritic spine development (GO:0060998) | 2.84387364 |
| 117 | L-amino acid import (GO:0043092) | 2.84347717 |
| 118 | primary amino compound metabolic process (GO:1901160) | 2.84093486 |
| 119 | neuronal action potential (GO:0019228) | 2.83325960 |
| 120 | potassium ion import (GO:0010107) | 2.82386106 |
| 121 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.81972686 |
| 122 | calcium ion-dependent exocytosis (GO:0017156) | 2.79440367 |
| 123 | central nervous system myelination (GO:0022010) | 2.77529927 |
| 124 | axon ensheathment in central nervous system (GO:0032291) | 2.77529927 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.89770263 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 4.06994936 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.99216481 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.92171333 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.89289359 |
| 6 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 2.69634844 |
| 7 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.49305166 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.49305166 |
| 9 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.45425561 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.45236823 |
| 11 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.44362267 |
| 12 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36608537 |
| 13 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.36588158 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.35998398 |
| 15 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.33677439 |
| 16 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.30012377 |
| 17 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.28053840 |
| 18 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.24391066 |
| 19 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 2.19422641 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.16133084 |
| 21 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.12822182 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.08788432 |
| 23 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.07800188 |
| 24 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.04193372 |
| 25 | * CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.96148482 |
| 26 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.91417143 |
| 27 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.87748264 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.87538656 |
| 29 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.84335374 |
| 30 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.82188788 |
| 31 | * CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.78522109 |
| 32 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.74410547 |
| 33 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.73383382 |
| 34 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.72795496 |
| 35 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.66453747 |
| 36 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.55933326 |
| 37 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.55750100 |
| 38 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.52351023 |
| 39 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49154207 |
| 40 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.46108605 |
| 41 | STAT3_23295773_ChIP-Seq_U87_Human | 1.44128850 |
| 42 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.42294341 |
| 43 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.41786098 |
| 44 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.41248738 |
| 45 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.40234254 |
| 46 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.39573846 |
| 47 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.39353812 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.37569274 |
| 49 | * PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36745779 |
| 50 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.36487315 |
| 51 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.34100923 |
| 52 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.32730875 |
| 53 | * AR_25329375_ChIP-Seq_VCAP_Human | 1.32693284 |
| 54 | * BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.32265482 |
| 55 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.31271185 |
| 56 | AR_19668381_ChIP-Seq_PC3_Human | 1.27952371 |
| 57 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.25745514 |
| 58 | TCF4_23295773_ChIP-Seq_U87_Human | 1.24617709 |
| 59 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.24077429 |
| 60 | * CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.24073911 |
| 61 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.23932460 |
| 62 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.23910713 |
| 63 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.23519912 |
| 64 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.20669302 |
| 65 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.18608594 |
| 66 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.18146094 |
| 67 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.16033390 |
| 68 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.15554218 |
| 69 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.14722740 |
| 70 | * ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.14690271 |
| 71 | * YAP1_20516196_ChIP-Seq_MESCs_Mouse | 1.14320619 |
| 72 | FUS_26573619_Chip-Seq_HEK293_Human | 1.12988660 |
| 73 | * IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.12666723 |
| 74 | * CBP_20019798_ChIP-Seq_JUKART_Human | 1.12666723 |
| 75 | * AHR_22903824_ChIP-Seq_MCF-7_Human | 1.09375994 |
| 76 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.09107536 |
| 77 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08142747 |
| 78 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.07389519 |
| 79 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.06976737 |
| 80 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.06901960 |
| 81 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05316092 |
| 82 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.04170300 |
| 83 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.03775584 |
| 84 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 1.03667573 |
| 85 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.03570946 |
| 86 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03314918 |
| 87 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.01381047 |
| 88 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.00668285 |
| 89 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.00524041 |
| 90 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.00500038 |
| 91 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.00051240 |
| 92 | VDR_22108803_ChIP-Seq_LS180_Human | 0.99839426 |
| 93 | * KDM2B_26808549_Chip-Seq_REH_Human | 0.99837059 |
| 94 | * SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.98954346 |
| 95 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.98371298 |
| 96 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.98253017 |
| 97 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.97287887 |
| 98 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96874765 |
| 99 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.96542547 |
| 100 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96542547 |
| 101 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.95819812 |
| 102 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.95334596 |
| 103 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.95173077 |
| 104 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.94444816 |
| 105 | * ER_23166858_ChIP-Seq_MCF-7_Human | 0.93971271 |
| 106 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93449721 |
| 107 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.92543091 |
| 108 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.89371250 |
| 109 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.88236216 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.74038895 |
| 2 | MP0003880_abnormal_central_pattern | 4.28227769 |
| 3 | * MP0003635_abnormal_synaptic_transmissio | 3.95465171 |
| 4 | MP0004270_analgesia | 3.76797066 |
| 5 | MP0009046_muscle_twitch | 3.34681959 |
| 6 | MP0009745_abnormal_behavioral_response | 3.25304185 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.14087577 |
| 8 | MP0002064_seizures | 3.10011048 |
| 9 | MP0002572_abnormal_emotion/affect_behav | 2.83801549 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.78147320 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.77105137 |
| 12 | MP0002272_abnormal_nervous_system | 2.69713410 |
| 13 | MP0002734_abnormal_mechanical_nocicepti | 2.67226570 |
| 14 | MP0001486_abnormal_startle_reflex | 2.53962143 |
| 15 | MP0001501_abnormal_sleep_pattern | 2.49117569 |
| 16 | MP0002822_catalepsy | 2.33901025 |
| 17 | MP0002735_abnormal_chemical_nociception | 2.18422349 |
| 18 | MP0009780_abnormal_chondrocyte_physiolo | 2.11395764 |
| 19 | MP0002067_abnormal_sensory_capabilities | 2.07062163 |
| 20 | MP0002909_abnormal_adrenal_gland | 2.03517755 |
| 21 | MP0002736_abnormal_nociception_after | 2.01065925 |
| 22 | MP0001440_abnormal_grooming_behavior | 1.98624460 |
| 23 | MP0002733_abnormal_thermal_nociception | 1.98508158 |
| 24 | MP0008569_lethality_at_weaning | 1.94035228 |
| 25 | MP0005646_abnormal_pituitary_gland | 1.91842506 |
| 26 | MP0002184_abnormal_innervation | 1.88417425 |
| 27 | MP0001970_abnormal_pain_threshold | 1.88042931 |
| 28 | MP0006276_abnormal_autonomic_nervous | 1.87084089 |
| 29 | MP0001984_abnormal_olfaction | 1.82318996 |
| 30 | MP0002557_abnormal_social/conspecific_i | 1.82161079 |
| 31 | MP0008877_abnormal_DNA_methylation | 1.80484534 |
| 32 | MP0004924_abnormal_behavior | 1.78768929 |
| 33 | MP0005386_behavior/neurological_phenoty | 1.78768929 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 1.76323703 |
| 35 | MP0003879_abnormal_hair_cell | 1.76036734 |
| 36 | MP0005645_abnormal_hypothalamus_physiol | 1.73605477 |
| 37 | MP0003787_abnormal_imprinting | 1.73146844 |
| 38 | MP0000778_abnormal_nervous_system | 1.63490358 |
| 39 | MP0003123_paternal_imprinting | 1.62231941 |
| 40 | MP0004811_abnormal_neuron_physiology | 1.59608935 |
| 41 | MP0003122_maternal_imprinting | 1.55914944 |
| 42 | MP0001188_hyperpigmentation | 1.54851268 |
| 43 | MP0001502_abnormal_circadian_rhythm | 1.51751390 |
| 44 | MP0010386_abnormal_urinary_bladder | 1.49095188 |
| 45 | * MP0002882_abnormal_neuron_morphology | 1.45686439 |
| 46 | MP0000955_abnormal_spinal_cord | 1.44199084 |
| 47 | MP0004858_abnormal_nervous_system | 1.43705815 |
| 48 | MP0002066_abnormal_motor_capabilities/c | 1.38764816 |
| 49 | MP0003329_amyloid_beta_deposits | 1.38756135 |
| 50 | MP0000569_abnormal_digit_pigmentation | 1.30070791 |
| 51 | MP0004142_abnormal_muscle_tone | 1.29570784 |
| 52 | MP0003633_abnormal_nervous_system | 1.29207099 |
| 53 | MP0004885_abnormal_endolymph | 1.25196691 |
| 54 | MP0004145_abnormal_muscle_electrophysio | 1.24966054 |
| 55 | MP0002229_neurodegeneration | 1.21699274 |
| 56 | MP0006072_abnormal_retinal_apoptosis | 1.21475780 |
| 57 | MP0001529_abnormal_vocalization | 1.20098282 |
| 58 | MP0001905_abnormal_dopamine_level | 1.13711018 |
| 59 | MP0004043_abnormal_pH_regulation | 1.13392903 |
| 60 | MP0002638_abnormal_pupillary_reflex | 1.11665287 |
| 61 | MP0003631_nervous_system_phenotype | 1.08005893 |
| 62 | MP0003283_abnormal_digestive_organ | 1.07106387 |
| 63 | MP0002152_abnormal_brain_morphology | 1.05798855 |
| 64 | MP0005499_abnormal_olfactory_system | 1.03979580 |
| 65 | MP0005394_taste/olfaction_phenotype | 1.03979580 |
| 66 | MP0002837_dystrophic_cardiac_calcinosis | 0.99757278 |
| 67 | MP0000013_abnormal_adipose_tissue | 0.99591712 |
| 68 | MP0004742_abnormal_vestibular_system | 0.98934270 |
| 69 | MP0000631_abnormal_neuroendocrine_gland | 0.94325043 |
| 70 | MP0002069_abnormal_eating/drinking_beha | 0.93775503 |
| 71 | MP0005253_abnormal_eye_physiology | 0.92022402 |
| 72 | MP0004085_abnormal_heartbeat | 0.91704181 |
| 73 | MP0005535_abnormal_body_temperature | 0.91314957 |
| 74 | MP0002090_abnormal_vision | 0.90810905 |
| 75 | MP0008872_abnormal_physiological_respon | 0.89602071 |
| 76 | MP0002752_abnormal_somatic_nervous | 0.86999683 |
| 77 | MP0001963_abnormal_hearing_physiology | 0.86393239 |
| 78 | MP0002876_abnormal_thyroid_physiology | 0.80399626 |
| 79 | MP0004215_abnormal_myocardial_fiber | 0.79808111 |
| 80 | MP0003634_abnormal_glial_cell | 0.78927253 |
| 81 | MP0003632_abnormal_nervous_system | 0.78477964 |
| 82 | MP0003890_abnormal_embryonic-extraembry | 0.78174696 |
| 83 | MP0001177_atelectasis | 0.75356721 |
| 84 | MP0003861_abnormal_nervous_system | 0.74185885 |
| 85 | MP0002653_abnormal_ependyma_morphology | 0.73078013 |
| 86 | MP0008874_decreased_physiological_sensi | 0.72417652 |
| 87 | MP0008961_abnormal_basal_metabolism | 0.71607173 |
| 88 | MP0005409_darkened_coat_color | 0.70367249 |
| 89 | MP0003195_calcinosis | 0.69951743 |
| 90 | MP0002102_abnormal_ear_morphology | 0.69556664 |
| 91 | MP0001485_abnormal_pinna_reflex | 0.69514368 |
| 92 | MP0000566_synostosis | 0.68978226 |
| 93 | MP0004233_abnormal_muscle_weight | 0.68758697 |
| 94 | MP0002693_abnormal_pancreas_physiology | 0.68724445 |
| 95 | MP0002082_postnatal_lethality | 0.67610946 |
| 96 | MP0010770_preweaning_lethality | 0.67610946 |
| 97 | MP0004133_heterotaxia | 0.67154709 |
| 98 | MP0004147_increased_porphyrin_level | 0.67119340 |
| 99 | MP0000751_myopathy | 0.66937301 |
| 100 | MP0003172_abnormal_lysosome_physiology | 0.65535038 |
| 101 | MP0003868_abnormal_feces_composition | 0.64987607 |
| 102 | MP0003183_abnormal_peptide_metabolism | 0.64691794 |
| 103 | MP0002751_abnormal_autonomic_nervous | 0.63612358 |
| 104 | * MP0010769_abnormal_survival | 0.63078088 |
| 105 | MP0003045_fibrosis | 0.62197254 |
| 106 | MP0003690_abnormal_glial_cell | 0.62067824 |
| 107 | MP0001299_abnormal_eye_distance/ | 0.61979701 |
| 108 | MP0000026_abnormal_inner_ear | 0.60963025 |
| 109 | MP0001986_abnormal_taste_sensitivity | 0.60499716 |
| 110 | MP0002234_abnormal_pharynx_morphology | 0.60409730 |
| 111 | * MP0010768_mortality/aging | 0.59787304 |
| 112 | MP0001944_abnormal_pancreas_morphology | 0.57991025 |
| 113 | MP0000920_abnormal_myelination | 0.57947751 |
| 114 | MP0003137_abnormal_impulse_conducting | 0.56712240 |
| 115 | MP0001943_abnormal_respiration | 0.55488850 |
| 116 | MP0005187_abnormal_penis_morphology | 0.55430995 |
| 117 | MP0003121_genomic_imprinting | 0.55106399 |
| 118 | MP0005379_endocrine/exocrine_gland_phen | 0.54651350 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.65536903 |
| 2 | Focal seizures (HP:0007359) | 5.76435528 |
| 3 | Myokymia (HP:0002411) | 5.58908109 |
| 4 | Visual hallucinations (HP:0002367) | 5.20490167 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.19858222 |
| 6 | Febrile seizures (HP:0002373) | 5.01502162 |
| 7 | Progressive cerebellar ataxia (HP:0002073) | 4.96012091 |
| 8 | Atonic seizures (HP:0010819) | 4.83671987 |
| 9 | Absence seizures (HP:0002121) | 4.58377627 |
| 10 | Dialeptic seizures (HP:0011146) | 4.13717946 |
| 11 | Action tremor (HP:0002345) | 4.08772423 |
| 12 | Generalized tonic-clonic seizures (HP:0002069) | 3.99597927 |
| 13 | Gaze-evoked nystagmus (HP:0000640) | 3.75537906 |
| 14 | Broad-based gait (HP:0002136) | 3.65111359 |
| 15 | Hyperventilation (HP:0002883) | 3.60760684 |
| 16 | Truncal ataxia (HP:0002078) | 3.33140080 |
| 17 | Genetic anticipation (HP:0003743) | 3.31531491 |
| 18 | Dysdiadochokinesis (HP:0002075) | 3.20623889 |
| 19 | Poor eye contact (HP:0000817) | 3.15309758 |
| 20 | Impaired smooth pursuit (HP:0007772) | 3.04643046 |
| 21 | Epileptiform EEG discharges (HP:0011182) | 3.04228039 |
| 22 | Supranuclear gaze palsy (HP:0000605) | 3.00004224 |
| 23 | Drooling (HP:0002307) | 2.98497882 |
| 24 | Excessive salivation (HP:0003781) | 2.98497882 |
| 25 | Depression (HP:0000716) | 2.95283730 |
| 26 | Dysmetria (HP:0001310) | 2.94310549 |
| 27 | Impaired social interactions (HP:0000735) | 2.93155741 |
| 28 | Abnormal social behavior (HP:0012433) | 2.93155741 |
| 29 | EEG with generalized epileptiform discharges (HP:0011198) | 2.90201301 |
| 30 | Anxiety (HP:0000739) | 2.88590213 |
| 31 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.84567881 |
| 32 | Scanning speech (HP:0002168) | 2.81233189 |
| 33 | Hepatoblastoma (HP:0002884) | 2.80878051 |
| 34 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.79981854 |
| 35 | Papilledema (HP:0001085) | 2.79694871 |
| 36 | Agitation (HP:0000713) | 2.74325539 |
| 37 | Amblyopia (HP:0000646) | 2.72846020 |
| 38 | Postural instability (HP:0002172) | 2.69413623 |
| 39 | Hypsarrhythmia (HP:0002521) | 2.68660348 |
| 40 | Ankle clonus (HP:0011448) | 2.66807923 |
| 41 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.64688763 |
| 42 | Hemiparesis (HP:0001269) | 2.63479054 |
| 43 | Absent speech (HP:0001344) | 2.61304635 |
| 44 | Diplopia (HP:0000651) | 2.50107365 |
| 45 | Abnormality of binocular vision (HP:0011514) | 2.50107365 |
| 46 | Mutism (HP:0002300) | 2.48866166 |
| 47 | Abnormal eating behavior (HP:0100738) | 2.48431407 |
| 48 | Abnormality of the labia minora (HP:0012880) | 2.47685791 |
| 49 | Central scotoma (HP:0000603) | 2.47058083 |
| 50 | Congenital stationary night blindness (HP:0007642) | 2.41254902 |
| 51 | Dysmetric saccades (HP:0000641) | 2.40621106 |
| 52 | Pheochromocytoma (HP:0002666) | 2.37298094 |
| 53 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.33348743 |
| 54 | Gait imbalance (HP:0002141) | 2.32796466 |
| 55 | Hemiplegia (HP:0002301) | 2.31686432 |
| 56 | Abnormality of macular pigmentation (HP:0008002) | 2.27915109 |
| 57 | Intention tremor (HP:0002080) | 2.25540888 |
| 58 | Status epilepticus (HP:0002133) | 2.24918516 |
| 59 | Spastic gait (HP:0002064) | 2.24697062 |
| 60 | Bradykinesia (HP:0002067) | 2.22335906 |
| 61 | Sleep apnea (HP:0010535) | 2.21458047 |
| 62 | Progressive inability to walk (HP:0002505) | 2.21321638 |
| 63 | Stereotypic behavior (HP:0000733) | 2.19444773 |
| 64 | Protruding tongue (HP:0010808) | 2.17438748 |
| 65 | Abnormality of the corticospinal tract (HP:0002492) | 2.11866713 |
| 66 | Blue irides (HP:0000635) | 2.11106416 |
| 67 | Fetal akinesia sequence (HP:0001989) | 2.04344556 |
| 68 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.03181988 |
| 69 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.03181988 |
| 70 | Abnormality of salivation (HP:0100755) | 2.02390668 |
| 71 | Generalized myoclonic seizures (HP:0002123) | 2.02313696 |
| 72 | Impaired vibratory sensation (HP:0002495) | 2.00399079 |
| 73 | Urinary urgency (HP:0000012) | 1.99531977 |
| 74 | Congenital primary aphakia (HP:0007707) | 1.98956570 |
| 75 | Neuroendocrine neoplasm (HP:0100634) | 1.98885877 |
| 76 | Limb dystonia (HP:0002451) | 1.96164254 |
| 77 | Spastic tetraplegia (HP:0002510) | 1.94371257 |
| 78 | Torticollis (HP:0000473) | 1.93990326 |
| 79 | Akinesia (HP:0002304) | 1.93946388 |
| 80 | Psychosis (HP:0000709) | 1.93809837 |
| 81 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.93674356 |
| 82 | Inability to walk (HP:0002540) | 1.91761420 |
| 83 | Gait ataxia (HP:0002066) | 1.90186276 |
| 84 | Polyphagia (HP:0002591) | 1.89731654 |
| 85 | Specific learning disability (HP:0001328) | 1.89241931 |
| 86 | Termporal pattern (HP:0011008) | 1.89194510 |
| 87 | Insidious onset (HP:0003587) | 1.89194510 |
| 88 | Focal dystonia (HP:0004373) | 1.87700906 |
| 89 | Medial flaring of the eyebrow (HP:0010747) | 1.87344040 |
| 90 | Increased circulating renin level (HP:0000848) | 1.87136674 |
| 91 | Postural tremor (HP:0002174) | 1.85887644 |
| 92 | Neurofibrillary tangles (HP:0002185) | 1.85463447 |
| 93 | Cerebral inclusion bodies (HP:0100314) | 1.85173319 |
| 94 | Megalencephaly (HP:0001355) | 1.83473901 |
| 95 | Ventricular fibrillation (HP:0001663) | 1.83054613 |
| 96 | Abnormal EKG (HP:0003115) | 1.82755784 |
| 97 | Nephronophthisis (HP:0000090) | 1.82163831 |
| 98 | Nephrogenic diabetes insipidus (HP:0009806) | 1.80498090 |
| 99 | Hypoglycemic seizures (HP:0002173) | 1.79704429 |
| 100 | Prolonged QT interval (HP:0001657) | 1.79685427 |
| 101 | Generalized hypopigmentation of hair (HP:0011358) | 1.79134960 |
| 102 | Oligodactyly (hands) (HP:0001180) | 1.78329821 |
| 103 | Abnormality of the lower motor neuron (HP:0002366) | 1.77067950 |
| 104 | Lower limb muscle weakness (HP:0007340) | 1.75264079 |
| 105 | Syncope (HP:0001279) | 1.74258359 |
| 106 | Morphological abnormality of the pyramidal tract (HP:0002062) | 1.73170599 |
| 107 | Incomplete penetrance (HP:0003829) | 1.72933944 |
| 108 | Pancreatic fibrosis (HP:0100732) | 1.72157424 |
| 109 | Inappropriate behavior (HP:0000719) | 1.71866997 |
| 110 | Volvulus (HP:0002580) | 1.71442733 |
| 111 | Obstructive sleep apnea (HP:0002870) | 1.70674362 |
| 112 | Chronic hepatic failure (HP:0100626) | 1.70555394 |
| 113 | Aqueductal stenosis (HP:0002410) | 1.70431442 |
| 114 | Widely spaced teeth (HP:0000687) | 1.70367346 |
| 115 | Decreased circulating renin level (HP:0003351) | 1.70021860 |
| 116 | Cerebral hypomyelination (HP:0006808) | 1.69993396 |
| 117 | Macroorchidism (HP:0000053) | 1.69368028 |
| 118 | Vaginal atresia (HP:0000148) | 1.69232789 |
| 119 | Failure to thrive in infancy (HP:0001531) | 1.67826778 |
| 120 | Genital tract atresia (HP:0001827) | 1.67311239 |
| 121 | Abnormality of the astrocytes (HP:0100707) | 1.66811161 |
| 122 | Astrocytoma (HP:0009592) | 1.66811161 |
| 123 | Muscular hypotonia of the trunk (HP:0008936) | 1.66188458 |
| 124 | Ketoacidosis (HP:0001993) | 1.65433623 |
| 125 | Poor coordination (HP:0002370) | 1.63485293 |
| 126 | Intellectual disability, severe (HP:0010864) | 1.62273229 |
| 127 | Hypoplasia of the corpus callosum (HP:0002079) | 1.61481447 |
| 128 | Exotropia (HP:0000577) | 1.61059905 |
| 129 | Alacrima (HP:0000522) | 1.60942324 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 5.07955731 |
| 2 | MAP3K4 | 3.36783038 |
| 3 | EPHA4 | 3.32283512 |
| 4 | MAP3K9 | 3.29035837 |
| 5 | MARK1 | 2.96406014 |
| 6 | MAP2K7 | 2.82773654 |
| 7 | CASK | 2.45555571 |
| 8 | MINK1 | 2.45504575 |
| 9 | NTRK2 | 2.11155334 |
| 10 | PAK6 | 2.09063048 |
| 11 | DAPK2 | 2.02882326 |
| 12 | MAP3K12 | 1.99118916 |
| 13 | MAP2K4 | 1.97591689 |
| 14 | PRKD3 | 1.93278894 |
| 15 | TNIK | 1.91100489 |
| 16 | PNCK | 1.87486427 |
| 17 | NTRK1 | 1.72497836 |
| 18 | CAMKK2 | 1.70031042 |
| 19 | RIPK4 | 1.67785932 |
| 20 | CAMKK1 | 1.61094576 |
| 21 | MAPK13 | 1.55298288 |
| 22 | DAPK1 | 1.50920042 |
| 23 | CDK5 | 1.48677561 |
| 24 | KSR2 | 1.41255998 |
| 25 | STK38 | 1.40809686 |
| 26 | INSRR | 1.40503696 |
| 27 | FGFR2 | 1.38928522 |
| 28 | MAP4K2 | 1.38651891 |
| 29 | PLK2 | 1.36813909 |
| 30 | CDK19 | 1.34622645 |
| 31 | GRK5 | 1.34285354 |
| 32 | PRPF4B | 1.32289797 |
| 33 | KSR1 | 1.30396473 |
| 34 | PRKCG | 1.26214091 |
| 35 | MAP3K2 | 1.25464217 |
| 36 | SIK2 | 1.19849640 |
| 37 | CAMK2A | 1.18228268 |
| 38 | UHMK1 | 1.17901032 |
| 39 | SGK2 | 1.11668562 |
| 40 | CAMK1D | 1.11320272 |
| 41 | SGK494 | 1.10288857 |
| 42 | SGK223 | 1.10288857 |
| 43 | AKT3 | 1.08187483 |
| 44 | BMPR2 | 1.03036961 |
| 45 | CAMK1G | 1.02210620 |
| 46 | FES | 1.00905945 |
| 47 | CAMK1 | 1.00027712 |
| 48 | CAMK2B | 0.97002588 |
| 49 | PRKCH | 0.92112243 |
| 50 | PAK3 | 0.91082141 |
| 51 | STK11 | 0.84176284 |
| 52 | WNK3 | 0.84085186 |
| 53 | PHKG1 | 0.83565234 |
| 54 | PHKG2 | 0.83565234 |
| 55 | SGK3 | 0.83228154 |
| 56 | CDC42BPA | 0.83023552 |
| 57 | OXSR1 | 0.82585147 |
| 58 | WNK1 | 0.82386392 |
| 59 | DYRK2 | 0.82133444 |
| 60 | DYRK1A | 0.77253689 |
| 61 | CDK18 | 0.77112759 |
| 62 | CSNK1G1 | 0.76777189 |
| 63 | RET | 0.73734026 |
| 64 | CDK15 | 0.73633205 |
| 65 | ARAF | 0.72044507 |
| 66 | CDK14 | 0.72029002 |
| 67 | CAMK2D | 0.71994401 |
| 68 | CSNK1G2 | 0.71677198 |
| 69 | CSNK1G3 | 0.70578700 |
| 70 | MARK2 | 0.69002122 |
| 71 | CSNK1A1L | 0.68189382 |
| 72 | PKN1 | 0.67193781 |
| 73 | BMPR1B | 0.66804086 |
| 74 | * SGK1 | 0.66619154 |
| 75 | TAOK1 | 0.65460194 |
| 76 | SIK3 | 0.65188450 |
| 77 | MAP3K13 | 0.65162633 |
| 78 | PRKCE | 0.64905656 |
| 79 | TYRO3 | 0.62986722 |
| 80 | CDK11A | 0.62536068 |
| 81 | MAP3K1 | 0.62428456 |
| 82 | PINK1 | 0.59897995 |
| 83 | NEK6 | 0.59490051 |
| 84 | TRIM28 | 0.59134170 |
| 85 | CSNK1E | 0.58256669 |
| 86 | STK39 | 0.53591737 |
| 87 | PTK2B | 0.53545832 |
| 88 | PDK1 | 0.53117841 |
| 89 | FRK | 0.53026139 |
| 90 | * RPS6KA3 | 0.52648278 |
| 91 | CSNK1D | 0.51563009 |
| 92 | HIPK2 | 0.50137069 |
| 93 | MAP3K6 | 0.49599677 |
| 94 | CAMK4 | 0.49553738 |
| 95 | CAMK2G | 0.49130409 |
| 96 | ADRBK2 | 0.47358478 |
| 97 | PRKAA1 | 0.47353839 |
| 98 | MAPK10 | 0.47014650 |
| 99 | PRKCZ | 0.46537628 |
| 100 | TNK2 | 0.46202713 |
| 101 | ALK | 0.46189463 |
| 102 | PDPK1 | 0.45083504 |
| 103 | GRK1 | 0.44848938 |
| 104 | BCR | 0.44481702 |
| 105 | LATS2 | 0.43670810 |
| 106 | FER | 0.43645409 |
| 107 | PRKCB | 0.42899075 |
| 108 | * GSK3B | 0.42812312 |
| 109 | PRKG1 | 0.41603787 |
| 110 | NME1 | 0.40618399 |
| 111 | FYN | 0.40409038 |
| 112 | * CSNK1A1 | 0.39797684 |
| 113 | WNK4 | 0.38784527 |
| 114 | CCNB1 | 0.38643544 |
| 115 | CDK3 | 0.38293241 |
| 116 | RAF1 | 0.38138032 |
| 117 | ERBB3 | 0.37707620 |
| 118 | PRKACA | 0.37611907 |
| 119 | MAP3K7 | 0.36905389 |
| 120 | PRKDC | 0.36426339 |
| 121 | STK38L | 0.36376976 |
| 122 | ACVR1B | 0.36109889 |
| 123 | ERBB2 | 0.33990699 |
| 124 | MAPK8 | 0.33960807 |
| 125 | PRKCA | 0.32827900 |
| 126 | * PRKACB | 0.28849886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.99571830 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.30260878 |
| 3 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.83279452 |
| 4 | GABAergic synapse_Homo sapiens_hsa04727 | 2.82663812 |
| 5 | Circadian entrainment_Homo sapiens_hsa04713 | 2.75573006 |
| 6 | Long-term potentiation_Homo sapiens_hsa04720 | 2.65271567 |
| 7 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.62104601 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.56857953 |
| 9 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.52427316 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 2.46254255 |
| 11 | * Insulin secretion_Homo sapiens_hsa04911 | 2.39041979 |
| 12 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.20588375 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.18408676 |
| 14 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.13053041 |
| 15 | Taste transduction_Homo sapiens_hsa04742 | 2.06622994 |
| 16 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.94594621 |
| 17 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.93936131 |
| 18 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.85542888 |
| 19 | Phototransduction_Homo sapiens_hsa04744 | 1.77028502 |
| 20 | Cocaine addiction_Homo sapiens_hsa05030 | 1.76886429 |
| 21 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.74320711 |
| 22 | Long-term depression_Homo sapiens_hsa04730 | 1.73780895 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.67556028 |
| 24 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.57409268 |
| 25 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.56065913 |
| 26 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.55521150 |
| 27 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.55392260 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.52596031 |
| 29 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.38483637 |
| 30 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.38351139 |
| 31 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.35064291 |
| 32 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.31526009 |
| 33 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.27545903 |
| 34 | Gap junction_Homo sapiens_hsa04540 | 1.19842042 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.19463049 |
| 36 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.18037935 |
| 37 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.15155450 |
| 38 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13370217 |
| 39 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.13311820 |
| 40 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.11933010 |
| 41 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.10820685 |
| 42 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.09379081 |
| 43 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.07499250 |
| 44 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.97022399 |
| 45 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.95004478 |
| 46 | Axon guidance_Homo sapiens_hsa04360 | 0.94779031 |
| 47 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.93549771 |
| 48 | Melanogenesis_Homo sapiens_hsa04916 | 0.92697885 |
| 49 | Glioma_Homo sapiens_hsa05214 | 0.92346997 |
| 50 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.91346102 |
| 51 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90898039 |
| 52 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.88901047 |
| 53 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.86352612 |
| 54 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.79549774 |
| 55 | Circadian rhythm_Homo sapiens_hsa04710 | 0.79076715 |
| 56 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.78935052 |
| 57 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.69621214 |
| 58 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.69549351 |
| 59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.69116860 |
| 60 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.68996738 |
| 61 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.68766131 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.68383742 |
| 63 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.67786043 |
| 64 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.66525167 |
| 65 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.65030809 |
| 66 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.63147202 |
| 67 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.60269424 |
| 68 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.59096382 |
| 69 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.59009410 |
| 70 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.58300652 |
| 71 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.55393239 |
| 72 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.54968074 |
| 73 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.53794902 |
| 74 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.53597536 |
| 75 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.53275583 |
| 76 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53194682 |
| 77 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.52960168 |
| 78 | Alcoholism_Homo sapiens_hsa05034 | 0.52242290 |
| 79 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.49682237 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.49260742 |
| 81 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.44157312 |
| 82 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43623023 |
| 83 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.41841286 |
| 84 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.40954347 |
| 85 | Bile secretion_Homo sapiens_hsa04976 | 0.40930744 |
| 86 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.40294867 |
| 87 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.40207702 |
| 88 | Alzheimers disease_Homo sapiens_hsa05010 | 0.39551002 |
| 89 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.39318401 |
| 90 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.39018016 |
| 91 | ABC transporters_Homo sapiens_hsa02010 | 0.38983565 |
| 92 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38634378 |
| 93 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.36829129 |
| 94 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.36147129 |
| 95 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.35522713 |
| 96 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.34853445 |
| 97 | Tight junction_Homo sapiens_hsa04530 | 0.34189640 |
| 98 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.33704737 |
| 99 | Lysine degradation_Homo sapiens_hsa00310 | 0.33667563 |
| 100 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.33342338 |
| 101 | Endometrial cancer_Homo sapiens_hsa05213 | 0.32975442 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.32433154 |
| 103 | Prion diseases_Homo sapiens_hsa05020 | 0.32410019 |
| 104 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31952266 |
| 105 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.30790001 |
| 106 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.30090954 |
| 107 | Endocytosis_Homo sapiens_hsa04144 | 0.29768593 |
| 108 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.28432884 |
| 109 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.27219526 |
| 110 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.26368339 |
| 111 | Histidine metabolism_Homo sapiens_hsa00340 | 0.25510889 |
| 112 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.25080553 |
| 113 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.24848103 |
| 114 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.23555277 |
| 115 | Mineral absorption_Homo sapiens_hsa04978 | 0.23529944 |
| 116 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.22733672 |

